VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression

J Woolard; W Wang; HS Bevan; Y Qiu; L Morbidelli; RO Pritchard-Jones; T-G Cui; M Sugiono; EC Waine; RM Perrin; RR Foster; J Digby-Bell; JD Shields; CE Whittles; RE Mushens; D Gillatt; M Ziche; SJ Harper; DO Bates

doi:10.1158/0008-5472.CAN-04-0934

VEGF₁₆₅b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression

J Woolard
, W Wang
, HS Bevan
, Y Qiu
, L Morbidelli
, RO Pritchard-Jones
, T-G Cui
, M Sugiono
, EC Waine
, RM Perrin
, RR Foster
, J Digby-Bell
, JD Shields
, CE Whittles
, RE Mushens
, D Gillatt
, M Ziche
, SJ Harper
, DO Bates

Research output: Contribution to journal › Article (Academic Journal) › peer-review

423 Citations (Scopus)

Translated title of the contribution	VEGF₁₆₅b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression
Original language	English
Pages (from-to)	7822 - 7835
Number of pages	14
Journal	Cancer Research
Volume	64 (21)
DOIs	https://doi.org/10.1158/0008-5472.CAN-04-0934
Publication status	Published - Nov 2004

Bibliographical note

Publisher: American Association for Cancer Research

Access to Document

10.1158/0008-5472.CAN-04-0934

http://intl-cancerres.aacrjournals.org/cgi/content/abstract/64/21/7822

Handle.net

Persistent link

Cite this

Woolard, J., Wang, W., Bevan, HS., Qiu, Y., Morbidelli, L., Pritchard-Jones, RO., Cui, T.-G., Sugiono, M., Waine, EC., Perrin, RM., Foster, RR., Digby-Bell, J., Shields, JD., Whittles, CE., Mushens, RE., Gillatt, D., Ziche, M., Harper, SJ., & Bates, DO. (2004). VEGF₁₆₅b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression. Cancer Research, 64 (21), 7822 - 7835. https://doi.org/10.1158/0008-5472.CAN-04-0934

@article{e8dc28021e32494fb96310ef36e4ca65,

title = "VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression",

author = "J Woolard and W Wang and HS Bevan and Y Qiu and L Morbidelli and RO Pritchard-Jones and T-G Cui and M Sugiono and EC Waine and RM Perrin and RR Foster and J Digby-Bell and JD Shields and CE Whittles and RE Mushens and D Gillatt and M Ziche and SJ Harper and DO Bates",

note = "Publisher: American Association for Cancer Research",

year = "2004",

month = nov,

doi = "10.1158/0008-5472.CAN-04-0934",

language = "English",

volume = "64 (21)",

pages = "7822 -- 7835",

journal = "Cancer Research",

issn = "1538-7445",

publisher = "American Association for Cancer Research Inc.",

}

Woolard, J, Wang, W, Bevan, HS, Qiu, Y, Morbidelli, L, Pritchard-Jones, RO, Cui, T-G, Sugiono, M, Waine, EC, Perrin, RM, Foster, RR, Digby-Bell, J, Shields, JD, Whittles, CE, Mushens, RE, Gillatt, D, Ziche, M, Harper, SJ & Bates, DO 2004, 'VEGF₁₆₅b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression', Cancer Research, vol. 64 (21), pp. 7822 - 7835. https://doi.org/10.1158/0008-5472.CAN-04-0934

TY - JOUR

T1 - VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, In vivo effect on angiogenesis and endogenous protein expression

AU - Woolard, J

AU - Wang, W

AU - Bevan, HS

AU - Qiu, Y

AU - Morbidelli, L

AU - Pritchard-Jones, RO

AU - Cui, T-G

AU - Sugiono, M

AU - Waine, EC

AU - Perrin, RM

AU - Foster, RR

AU - Digby-Bell, J

AU - Shields, JD

AU - Whittles, CE

AU - Mushens, RE

AU - Gillatt, D

AU - Ziche, M

AU - Harper, SJ

AU - Bates, DO

N1 - Publisher: American Association for Cancer Research

PY - 2004/11

Y1 - 2004/11

U2 - 10.1158/0008-5472.CAN-04-0934

DO - 10.1158/0008-5472.CAN-04-0934

M3 - Article (Academic Journal)

SN - 1538-7445

VL - 64 (21)

SP - 7822

EP - 7835

JO - Cancer Research

JF - Cancer Research

ER -